KEAP1/nuclear factor E2-related factor (NRF2) mutation happens approximately 30% of NSCLC (92), and 7% of patients have co-mutations of KEAP1/NRF2 and EGFR (113). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.